VIVS
$1.80
Pre-MarketAs of Mar 17, 8:00 PM UTC
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine.
Intraday
Custom Range:to
No data available for this range. Intraday data may be limited by the exchange.
Recent News
NIO January Deliveries Nearly Double Year On Year
EV maker opens 2026 with strong momentum
Top Midday Gainers
VivoSim Labs (VIVS) said late Thursday it signed agreements appointing JCBio as its distributor in S
BC-Most Active Stocks
GCL Global Holdings Ltd. 49,480,730 1.29
Wall Street Set to Open Lower Friday as Investors React to Trump's Choice of Warsh as Fed Chair
US stocks look set to open lower in Friday's trading session as investors seem calmed by President D
Rivian vs. NIO: Which EV Manufacturer Stock Is Worth Buying?
RIVN's upcoming R2 SUV, aggressive cost cuts and a multibillion-dollar Volkswagen partnership give it an edge over NIO in the EV stock debate.